APA (7th ed.) Citation

A, A., M, O., MP, H., & MD, J. (2026). Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders. Nature reviews. Clinical oncology, 23(7), 520. https://doi.org/10.1038/s41571-026-01147-w

Chicago Style (17th ed.) Citation

A, Ali, Ozdemirli M, Hamilton MP, and Jain MD. "Spectrum, Pathobiology, Mechanistic Insights and Diagnostic Challenges of Post-CAR T Cell Therapy Lymphoproliferative Disorders." Nature Reviews. Clinical Oncology 23, no. 7 (2026): 520. https://doi.org/10.1038/s41571-026-01147-w.

MLA (9th ed.) Citation

A, Ali, et al. "Spectrum, Pathobiology, Mechanistic Insights and Diagnostic Challenges of Post-CAR T Cell Therapy Lymphoproliferative Disorders." Nature Reviews. Clinical Oncology, vol. 23, no. 7, 2026, p. 520, https://doi.org/10.1038/s41571-026-01147-w.